gptkbp:instanceOf
|
Medical device company
|
gptkbp:acquiredBy
|
gptkb:Covidien
|
gptkbp:acquisitionYear
|
2015
|
gptkbp:annualR&DSpending
|
Over $2 billion
|
gptkbp:awards
|
gptkb:Forbes_Global_2000
gptkb:Fortune_World's_Most_Admired_Companies
|
gptkbp:CEO
|
gptkb:Geoff_Martha
|
gptkbp:diversityInitiatives
|
Yes
|
gptkbp:division
|
gptkb:Cardiac_and_Vascular_Group
gptkb:Diabetes_Group
gptkb:Minimally_Invasive_Therapies_Group
gptkb:Restorative_Therapies_Group
|
gptkbp:environmentalImpact
|
Yes
|
gptkbp:foundedBy
|
gptkb:Earl_Bakken
gptkb:Palmer_Hermundslie
|
gptkbp:foundedIn
|
gptkb:Minneapolis,_Minnesota,_United_States
|
gptkbp:foundedYear
|
1949
|
gptkbp:headquartersLocation
|
gptkb:Dublin,_Ireland
gptkb:Fridley,_Minnesota,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label
|
Medtronic
|
gptkbp:industry
|
Medical devices
|
gptkbp:ISIN
|
IE00BTN1Y115
|
gptkbp:listedOn
|
gptkb:New_York_Stock_Exchange
|
gptkbp:logo
|
Medtronic logo.svg
|
gptkbp:marketCap
|
Over $100 billion (2023)
|
gptkbp:netIncome
|
$3.76 billion (2023)
|
gptkbp:notableEmployee
|
gptkb:Earl_Bakken
|
gptkbp:notableEvent
|
Moved headquarters to Ireland for tax inversion (2015)
|
gptkbp:notableProduct
|
gptkb:First_battery-powered_external_pacemaker
|
gptkbp:numberOfEmployees
|
95000
|
gptkbp:officialWebsite
|
https://www.medtronic.com/
|
gptkbp:operatesIn
|
Over 150 countries
|
gptkbp:parentCompany
|
None (independent)
|
gptkbp:patent
|
Over 49,000
|
gptkbp:products
|
Defibrillators
Insulin pumps
Neurostimulators
Pacemakers
Surgical instruments
|
gptkbp:publiclyTraded
|
Yes
|
gptkbp:revenue
|
$31.23 billion (2023)
|
gptkbp:sentence
|
To alleviate pain, restore health, and extend life
|
gptkbp:stockExchange
|
gptkb:NYSE
gptkb:S&P_500
|
gptkbp:stockSymbol
|
MDT
|
gptkbp:subsidiary
|
gptkb:Covidien
gptkb:HeartWare_International
gptkb:Mazor_Robotics
gptkb:NaviMedix
|
gptkbp:tradedOn
|
gptkb:NYSE:_MDT
|
gptkbp:bfsParent
|
gptkb:Shirley_Ann_Jackson
|
gptkbp:bfsLayer
|
3
|